Logo

MBI Raises $4.5M in VC Funding to Develop Nanofluidic DNA Typing Platform

Sep 04, 2006
NEW YORK (GenomeWeb News) - Microchip Biotechnologies said last week that it has completed a Series A investment round worth $4.5 million.
 
The round was co-led by venture capital firms In-Q-Tel and RONA Syndicates.
 
MBI said it plans to use the funding to develop portable forensics devices for DNA typing based on its Microscale On-chip Valve, or MOV, nanofluidic platform.

Breaking News
The Scan

Expanded Genetic Testing Uncovers Hereditary Cancer Risk in Significant Subset of Cancer Patients

In Genome Medicine, researchers found pathogenic or likely pathogenic hereditary cancer risk variants in close to 17 percent of the 17,523 patients profiled with expanded germline genetic testing.

Mitochondrial Replacement Therapy Embryos Appear Largely Normal in Single-Cell 'Omics Analyses

Embryos produced with spindle transfer-based mitochondrial replacement had delayed demethylation, but typical aneuploidy and transcriptome features in a PLOS Biology study.

Cancer Patients Report Quality of Life Benefits for Immune Checkpoint Inhibitors

Immune checkpoint inhibitor immunotherapy was linked in JAMA Network Open to enhanced quality of life compared to other treatment types in cancer patients.

Researchers Compare WGS, Exome Sequencing-Based Mendelian Disease Diagnosis

Investigators find a diagnostic edge for whole-genome sequencing, while highlighting the cost advantages and improving diagnostic rate of exome sequencing in EJHG.